Recent Updates
Recently added Catalysts
ELAN Positive Sentiment Score: 70/100

Elanco Animal Health 2500 Innovation Way Greenfield, IN 46140 FOR IMMEDIATE RELEASE Media Contact: Colleen Parr Dekker, +1.317.989.7011, colleen.dekker@elancoah.com Investor Contact: Kathryn Grissom, +1.317.273.9284, kat

Key Takeaway: Elanco Animal Health has announced that its Board of Directors is undertaking a review of the company's corporate governance documents. This is part of a broader effort to enhance governance following their 2023 Annual Meeting. Shareholder approval will be sought at the 2024 Annual Meeting for proposed amendments to the Articles of Incorporation, aimed at improving shareholder communication and engagement. The company's ongoing commitment to corporate governance is emphasized by their removal of supermajority voting requirements in the past.

Market Sentiment Analysis

POSITIVE FACTORS

  • Elanco is enhancing its corporate governance structure based on shareholder feedback.
  • The company recently removed supermajority vote requirements which is a step towards increased shareholder empowerment.
  • Elanco's commitment to strong corporate governance reflects positively on its operations.

Full Press Release Details

Media Contact: Colleen Parr Dekker,
Investor Contact: Kathryn Grissom, +1.317.273.9284,
Elanco Announces Corporate Governance Enhancements
GREENFIELD, Ind. (October 4,
2023) - Elanco Animal Health Incorporated (NYSE: ELAN) announced today that the Board of Directors has commenced a process
to amend the Company's corporate governing documents as part of a comprehensive governance review following the Company's
2023 Annual Meeting of Shareholders. The Board expects to seek shareholder approval at the 2024 Annual Meeting of Shareholders for amendments
to the Company's Articles of Incorporation that will:
"We have engaged with our shareholders, particularly during the
past three years, on corporate governance matters," said R. David Hoover, Chairman of the Board and the Corporate Governance Committee.
"We value our shareholders' opinions and appreciate the feedback we have received that informed the Board's actions."
"Last year we eliminated the supermajority vote requirements
to amend the Company's Articles of Incorporation and Bylaws," Hoover continued. "Given the solid foundation Elanco has
built during the five years since our IPO, we believe now is the time to make these additional governance changes. At Elanco, we are committed
to strong corporate governance and will continue to foster open communication with our shareholders."
More information regarding the proposals requiring shareholder approval
will be included in the Company's proxy statement to be filed with the Securities and Exchange Commission prior to the 2024 Annual
Meeting of Shareholders. The proposed amendments to the Articles of Incorporation will not be effective unless and until shareholders
approve such amendments. Upon shareholder approval, the amended Articles of Incorporation and Bylaws will be filed with the Securities
and Exchange Commission.
Elanco Animal Health Incorporated (NYSE:
ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in
farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years
of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a
meaningful impact on our local and global communities. At Elanco, we are driven by our vision of Food and Companionship Enriching Life
and our Elanco Healthy Purpose Sustainability Pledges -all to advance the health of animals, people, and the planet. Learn

Frequently Asked Questions

What announcements did Elanco make on October 4, 2023?

Elanco announced plans to amend its corporate governance documents post-2023 Annual Meeting.

Who commented on Elanco's corporate governance changes?

R. David Hoover, Chairman of the Board, discussed the governance changes.

When will shareholders vote on the proposed governance amendments?

Shareholders are expected to vote on the amendments at the 2024 Annual Meeting.

What significant change was made last year in Elanco's governance?

Last year, Elanco removed the supermajority vote requirement for amendments.

What is Elanco's commitment regarding corporate governance?

Elanco is dedicated to strong corporate governance and open shareholder communication.

Last updated: Oct 4, 2023